<code id='95ADB8EBA2'></code><style id='95ADB8EBA2'></style>
    • <acronym id='95ADB8EBA2'></acronym>
      <center id='95ADB8EBA2'><center id='95ADB8EBA2'><tfoot id='95ADB8EBA2'></tfoot></center><abbr id='95ADB8EBA2'><dir id='95ADB8EBA2'><tfoot id='95ADB8EBA2'></tfoot><noframes id='95ADB8EBA2'>

    • <optgroup id='95ADB8EBA2'><strike id='95ADB8EBA2'><sup id='95ADB8EBA2'></sup></strike><code id='95ADB8EBA2'></code></optgroup>
        1. <b id='95ADB8EBA2'><label id='95ADB8EBA2'><select id='95ADB8EBA2'><dt id='95ADB8EBA2'><span id='95ADB8EBA2'></span></dt></select></label></b><u id='95ADB8EBA2'></u>
          <i id='95ADB8EBA2'><strike id='95ADB8EBA2'><tt id='95ADB8EBA2'><pre id='95ADB8EBA2'></pre></tt></strike></i>

          leisure time

          leisure time

          author:comprehensive    Page View:3534
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Why hospitals are withdrawing from US News rankings
          Why hospitals are withdrawing from US News rankings

          UniversityofPennsylvaniahospitalcomplexJonLovette/AlamyMercyPhiladelphiaHospitalwasplanningonshuttin

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Sickle cell gene therapy cures need to be accessible in Africa

          Redbloodcellsfromapersonwithsicklecelldisease.JonathanArmstrong/WellcomeThetreatmentofsicklecelldise